Concepedia

Bryan B. Molloy

BB

48

Publications

2.7K

Citations

28

H-Index

1961

Active since

Affiliations

Eli Lilly (United States)(Current)

Bryan B. Molloy is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1961–1986

48

Publications

48

A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine

David T. Wong, Jong S. Horng, Frank P. Bymaster et al. · Life Sciences · 1974 · 475 citations

, , +3

A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.

Dawn M. Wong, Frank P. Bymaster, Jong S. Horng et al. · Journal of Pharmacology and Experimental Therapeutics · 1975 · 370 citations

Effect of an uptake inhibitor on serotonin metabolism in rat brain: Studies with 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine (Lilly 110140)

Ray W. Fuller, Kenneth W. Perry, Bryan B. Molloy · Life Sciences · 1974 · 206 citations

, , +9

Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine

Ray W. Fuller, Kenneth W. Perry, Bryan B. Molloy · European Journal of Pharmacology · 1975 · 109 citations

, , +7

Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine.

Ray W. Fuller, Kenneth W. Perry, Bryan B. Molloy · PubMed · 1975 · 101 citations

, , +16

Rows per page

1–5 of 48